Semi-annual evaluation report on the company's "Improving Quality and Efficiency, Returning to Profit" action plan for 2024 of Remegen Pharmaceutical (Yantai) Co., Ltd.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.